Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug

benzinga.com/m-a/25/07/46317822/merck-strikes-10-billion-deal-for-verona-secures-first-in-class-copd-drug

Merck & Co. Inc. (NYSE:MRK) agreed on Wednesday to acquire Verona Pharma plc (NASDAQ:VRNA) for $107 per American Depository Share (ADS) for a total transaction value of approximately $10 billion. Each ADS represents eight ordinary shares of Verona Pharma.
Through the acquisition of this…

This story appeared on benzinga.com, 2025-07-09 13:03:53.
The Entire Business World on a Single Page. Free to Use →